3rd ESTRO Forum 2015 could involve schedules employing fewer fractions than CFRT, but more than in a typical SBRT treatment while partly escalating the fractional dose. It was the purpose of this study to investigate heterogeneous fractionation patterns with respect to the dose per fraction, taking into account the spatial and dynamic aspects of the tumour oxygenation and the effect of accelerated repopulation of tumour cells in treatments extending over several weeks. Materials and Methods: Three-dimensional in silico tumours with heterogeneous oxygenation were simulated based on previous calculations from intervessel distance distributions. Homogeneous dose delivery was simulated employing 2 Gy per fraction as baseline and partly escalating the dose to 3 and 4 Gy per fraction corresponding to fractions delivered prior to or directly following a short interruption of the treatment as represented by the weekends. Survival was assessed on voxel level with the linear-quadratic (LQ) model taking into account the dose-modifying effect of the oxygenation. The effect of accelerated repopulation was incorporated assuming a kick-off time of 14 days and a potential doubling time of 5 days for NSCLC. Local control was evaluated as tumour control probability (TCP) through a Poisson-based model and dose-response curves were generated by systematically varying the total dose. Results: For tumours with a negligible level of spread-out hypoxia (left panel of Figure 1 ) and assuming that accelerated repopulation starts after two weeks, partly increasing the fractional dose could substantially improve local control even if no reoxygenation takes place. If however the effects of repopulation are neglected and the hypoxia is geometrically concentrated instead of being spread out throughout the tumour, the impact of reoxygenation is far more important than partly escalating the fractional dose, even for small hypoxic fractions (right panel of Figure 1 ).
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Conclusions:
Heterogeneous fractionation might ensure high levels of control in well-oxygenated tumours even when inter-fraction reoxygenation cannot be assumed. For tumours with more concentrated hypoxia, moderately heterogeneous fractionation patterns cannot counteract the increased radioresistance of tumour hypoxia. 2008-006302-42) treating LAPC with chemoradiotherapy were chosen for this study. CBCTs from fractions 6, 12, 18 and 24 were fused with the planning CT using a bony and soft tissue match. The duodenum was contoured on the planning CT and each CBCT by a single physician. The contours were copied to the ARCII trial 3D conformal plan prescribing 50.4Gy in 28 fractions to the PTV with a subsequent boost of 9Gy in 5 fractions to a smaller PTV for a total of 59.4Gy. The total volume of the duodenum and the percentage of the duodenum outside of the PTV (% out) were recorded together with V35 and V55 from the duodenum dose surface histograms (DSHs). Results: The volume of the duodenum on the planning CT and the range of duodenum volumes over the 4 CBCT contours were 86.6cm 3 (56.7 -71.9), 41.6cm 3 (45.9 -80.6) and 93.1cm 3 (76.7 -132.7) for patients 1, 2 and 3 respectively. Figure 1 shows large interfraction variation in the volume of the duodenum. There is also variation in the percentage of the duodenum located outside the PTV. It is also seen that as more of the duodenum is found outside the PTV, the dose volume metrics of the duodenum are reduced. There is no such link to absolute volume change.
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Conclusions: Results confirm previous studies showing large variation in duodenum volume between fractions in a given patient. For patients where the duodenum and PTV overlap, evaluation of volume receiving dose around 30-55Gy presents the largest error due to interfraction differences. This study suggests that a reduction in dose volume metrics of the duodenum is likely to be due to an increase in the percentage of the duodenum located outside the PTV. However, this parameter still suffers from interfraction effects. These finding suggest that toxicity predictions based on either duodenum volume, percentage of duodenum outside PTV or the DSH from the planning CT alone may be inaccurate. Further work needs to be undertaken in order to better estimate toxicity. figure) . This effect increases with an increasing peak to valley dose ratio (PVDR). We were able to attribute this effect to a convex dose-response relationship. Furthermore we were able to show that the vascular network morphology has a strong influence on the tissue damage after MRT exposure. Especially the distribution of vessel radii appears to be crucial. This may explain the differential effect on tumours and normal tissue.
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